Personalis, Inc. (PSNL): who owns it and who trades it
As of Nov 16, 2026, PSNL insiders reported 16 open-market sales worth $9M and 12 purchases worth $2.7M in the last 12 months, with 92% of the sale value made under pre-set 10b5-1 plans. The largest seller was Christopher M Hall (CEO), with $4.5M. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Personalis
From the latest filingsOverall: more buying than selling. Funds, insiders and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns PSNL
158 funds and institutions reported PSNL shares worth $1.1B at the end of Q2 2026, about 81% of the company. The largest holder is Merck & Co., Inc. with 13.4%.
Funds and institutions (13F) 81%Everyone else 19%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Merck & Co., Inc. | 14.04M | 13.41% | $188M | No change |
| ARK Investment Management LLC | 8.27M | 7.90% | $111M | +4% |
| BlackRock, Inc. | 7.08M | 6.76% | $94.9M | +31% |
| Lightspeed Management Company, L.l.c. | 6.10M | 5.83% | $81.8M | -25% |
| Ameriprise Financial Inc | 6.09M | 5.81% | $81.6M | -20% |
| Deep Track Capital, LP | 4.00M | 3.82% | $53.6M | +33% |
| Aberdeen Group plc | 3.75M | 3.58% | $50.2M | +7% |
| Vanguard Capital Management LLC | 3.01M | 2.87% | $40.3M | +5% |
| Casdin Capital, LLC | 2.55M | 2.44% | $34.2M | +59% |
| Kennedy Capital Management LLC | 2.36M | 2.26% | $31.7M | +8% |
| Geode Capital Management, LLC | 1.82M | 1.74% | $24.4M | +40% |
| Bank of America Corp | 1.82M | 1.74% | $24.4M | +1536% |
| AIGH Capital Management LLC | 1.72M | 1.64% | $23M | -41% |
| Blue Water Life Science Advisors, LP | 1.68M | 1.60% | $22.5M | No change |
| Dimensional Fund Advisors LP | 1.50M | 1.43% | $20.1M | +40% |
| State Street Corp | 1.49M | 1.42% | $19.9M | +31% |
| Morgan Stanley | 1.27M | 1.21% | $17M | +436% |
| Goldman Sachs Group Inc | 931,031 | 0.89% | $12.5M | +26% |
| Hrt Financial LP | 930,816 | 0.89% | $12.5M | +346% |
| Nuveen, LLC | 753,004 | 0.72% | $10.1M | +119% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, PSNL insiders reported $2.7M of open-market purchases and $9M of sales. 92% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | Christopher M Hall | CEO | Sale | 29,112 | $15.87 | $462K | Form 4 |
| Sep 18, 2026 | Stephen Michael Moore | Vice president | Sale | 2,068 | $16.22 | $33.5K | Form 4 |
| Sep 18, 2026 | Richard Chen | President | Sale | 3,998 | $16.22 | $64.8K | Form 4 |
| Sep 18, 2026 | Christopher M Hall | CEO | Sale | 7,459 | $16.22 | $121K | Form 4 |
| Sep 18, 2026 | Aaron Tachibana | CFO | Sale | 2,931 | $16.22 | $47.5K | Form 4 |
| Jul 15, 2026 | Richard Chen | President | Sale plan | 100,000 | $15.15 | $1.5M | Form 4 |
| Jul 9, 2026 | Christopher M Hall | CEO | Sale plan | 100,000 | $15.08 | $1.5M | Form 4 |
| Jun 29, 2026 | Aaron Tachibana | CFO | Sale plan | 4,982 | $14.00 | $69.7K | Form 4 |
| Jun 26, 2026 | Aaron Tachibana | CFO | Sale plan | 51,251 | $13.18 | $675K | Form 4 |
| Jun 26, 2026 | Christopher M Hall | CEO | Sale plan | 100,000 | $13.15 | $1.3M | Form 4 |
| Jun 4, 2026 | Aaron Tachibana | CFO | Sale plan | 40,000 | $12.01 | $480K | Form 4 |
| May 29, 2026 | Christopher M Hall | CEO | Sale plan | 80,091 | $11.02 | $883K | Form 4 |
| May 29, 2026 | Aaron Tachibana | CFO | Sale plan | 38,799 | $11.58 | $449K | Form 4 |
| May 28, 2026 | Christopher M Hall | CEO | Sale plan | 19,909 | $11.02 | $219K | Form 4 |
| Jan 22, 2026 | Aaron Tachibana | CFO | Sale plan | 1,201 | $11.50 | $13.8K | Form 4 |
| Dec 22, 2025 | Tempus AI, Inc. | 10% owner | Purchase | 28,000 | $8.93 | $250K | Form 4 |
| Dec 19, 2025 | Tempus AI, Inc. | 10% owner | Purchase | 29,641 | $8.39 | $249K | Form 4 |
| Dec 18, 2025 | Tempus AI, Inc. | 10% owner | Purchase | 31,430 | $7.91 | $249K | Form 4 |
| Dec 17, 2025 | Tempus AI, Inc. | 10% owner | Purchase | 31,650 | $7.86 | $249K | Form 4 |
| Nov 25, 2025 | Tempus AI, Inc. | 10% owner | Purchase | 13,888 | $11.00 | $153K | Form 4 |
| Nov 25, 2025 | Tempus AI, Inc. | 10% owner | Purchase | 9,712 | $10.08 | $97.9K | Form 4 |
| Nov 25, 2025 | Aaron Tachibana | CFO | Sale plan | 103,668 | $10.78 | $1.1M | Form 4 |
| Nov 24, 2025 | Tempus AI, Inc. | 10% owner | Purchase | 25,225 | $9.87 | $249K | Form 4 |
| Nov 21, 2025 | Tempus AI, Inc. | 10% owner | Purchase | 9,900 | $8.84 | $87.5K | Form 4 |
| Nov 21, 2025 | Tempus AI, Inc. | 10% owner | Purchase | 16,599 | $9.74 | $162K | Form 4 |
| Nov 20, 2025 | Tempus AI, Inc. | 10% owner | Purchase | 28,827 | $8.63 | $249K | Form 4 |
| Nov 19, 2025 | Tempus AI, Inc. | 10% owner | Purchase | 30,645 | $8.12 | $249K | Form 4 |
| Nov 18, 2025 | Tempus AI, Inc. | 10% owner | Purchase | 64,750 | $7.67 | $497K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Christopher M Hall | Chief Executive Officer, Director | – | $4.5M | Nov 3, 2026 |
| Aaron Tachibana | CFO AND COO | – | $2.9M | Sep 18, 2026 |
| Tempus AI, Inc. | 10% owner | $2.7M | – | Dec 22, 2025 |
| Richard Chen | President and CMO | – | $1.6M | Sep 18, 2026 |
| Stephen Michael Moore | SVP and Chief Legal Officer | – | $33.5K | Sep 18, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
PSNL short interest
Moderate short interest. 6.2% of PSNL shares are sold short: about 1 share in 16. Over the last 12 reports the number of shares short went down 51%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 6.75M PSNL shares were sold short, 6.2% of the shares outstanding, down 0.7% from the report before. At the average daily volume of 2.02M shares, buying them all back would take about 3.3 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 6.75M | 6.22% | -1% | 2.02M | 3.3 |
| Oct 15, 2026 | 6.79M | 6.36% | -19% | 2.57M | 2.6 |
| Sep 30, 2026 | 8.43M | 7.89% | +2% | 1.95M | 4.3 |
| Sep 15, 2026 | 8.27M | 7.74% | -1% | 2.33M | 3.5 |
| Aug 31, 2026 | 8.38M | 7.85% | -0% | 4.67M | 1.8 |
| Aug 14, 2026 | 8.40M | 7.86% | -4% | 2.33M | 3.6 |
| Jul 31, 2026 | 8.71M | 8.16% | -21% | 5.15M | 1.7 |
| Jul 15, 2026 | 11.10M | 10.60% | -2% | 4.75M | 2.3 |
| Jun 30, 2026 | 11.31M | 10.80% | +2% | 4.07M | 2.8 |
| Jun 15, 2026 | 11.10M | 10.60% | -13% | 3.09M | 3.6 |
| May 29, 2026 | 12.83M | 12.25% | -7% | 2.98M | 4.3 |
| May 15, 2026 | 13.73M | 13.12% | +5% | 2.43M | 5.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Personalis company events
Personalis filed 15 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 4, 2026.
- Nov 4, 2026ResultsReleased financial results. Filing
- Oct 6, 2026AnnouncementAs previously disclosed, on July 20, 2026, Personalis, Inc., a Delaware corporation, entered into an Agreement and Plan of Merger with Tempus AI, Inc., a Nevada corporation, Aviary Development, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent, and Toucan Development… Filing
- Aug 20, 2026AnnouncementPersonalis, Inc. received a new task order under its contract with the U.S. Department of Veterans Affairs (VA) for the VA's Million Veteran Program (VA MVP). Filing
- Aug 4, 2026ResultsReleased financial results. Filing
- Jul 20, 2026AgreementPersonalis, Inc., a Delaware corporation, entered into an Agreement and Plan of Merger by and among the Company, Tempus AI, Inc., a Nevada corporation, Aviary Development, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent and Toucan Development, LLC, a Nevada limited liability… Filing
- Jul 20, 2026ResultsReleased financial results. Filing
- May 20, 2026AnnouncementOn May19, 2026, the Centers for Medicare & Medicaid Services Molecular Diagnostics Program expanded Medicare coverage for Personalis, Inc.’s ultrasensitive NeXT Personal ® test to include monitoring treatment response to neoadjuvant therapy (NAT) in patients diagnosed with Stage II-III… Filing
- May 13, 2026VoteReported shareholder vote results. Filing
- May 13, 2026AnnouncementOn May12, 2026, the Centers for Medicare & Medicaid Services Molecular Diagnostics Program expanded Medicare coverage for our ultrasensitive NeXT Personal ® test to include immunotherapy monitoring for patients with late-stage solid tumors. Filing
- May 7, 2026ResultsReleased financial results. Filing
- Mar 17, 2026LeadershipDeparture of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers. Filing
- Feb 26, 2026ResultsReleased financial results. Filing
- Jan 8, 2026ResultsReleased financial results. Filing
- Nov 28, 2025AnnouncementPersonalis, Inc. filed a prospectus supplement to the prospectus included in the Company’s shelf registration statement on Form S-3 (Registration No. 333-276204), relating to the offer and sale of up to $100 million of shares of the Company’s common stock pursuant to that certain Amended and… Filing
- Nov 25, 2025AnnouncementThe Centers for Medicare & Medicaid Services Molecular Diagnostics Program revised its reimbursement rate determination for Medicare coverage for our ultrasensitive NeXT Personal ® test for post-treatment surveillance of cancer recurrence in patients with stage II and III breast cancer. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Personalis financials
Famous investors that hold PSNL
5 of the 50 well-known investors we track reported holding PSNL in their latest 13F filing. The largest position is Cathie Wood's, worth $116M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Cathie Wood · ARK Investment Management | Q3 2026 | 7.12M | $116M | 0.7% | -14% |
| Israel Englander · Millennium Management | Q3 2026 | 1.11M | $18M | 0.0% | +146% |
| George Soros · Soros Fund Management | Q3 2026 | 250,000 | $4.1M | 0.1% | New |
| Ken Griffin · Citadel Advisors | Q3 2026 | 132,235 | $2.2M | 0.0% | -9% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 126,427 | $2.1M | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named PSNL in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Ameriprise Financial, Inc. | 13G/A | 1.0% |
| Nov 16, 2026 | Ameriprise Financial, Inc. | 13G/A | 1.0% |
| Nov 13, 2026 | ARK Investment Management LLC | 13G/A | 6.7% |
| Nov 13, 2026 | ARK Investment Management LLC | 13G/A | 6.7% |
Questions about Personalis, Inc. (PSNL) stock
Who owns the most PSNL stock?
The largest reported owner of Personalis, Inc. (PSNL) is Merck & Co., Inc., with 13.4% of the company. In total, 158 funds and institutions reported holding PSNL at the end of Q2 2026, together about 81% of the shares. See the largest owners.
Are PSNL insiders buying or selling?
In the last 12 months, PSNL insiders reported 12 open-market purchases worth $2.7M and 16 sales worth $9M. The latest trade was on Nov 3, 2026. See every trade.
What is the short interest in PSNL?
As of Oct 30, 2026, 6.75M PSNL shares were sold short, 6.2% of the shares outstanding, down 0.7% from the report before. At the average daily volume of 2.02M shares, buying them all back would take about 3.3 trading days (days to cover). See the history.
Which famous investors hold PSNL?
5 of the 50 well-known investors we track reported PSNL in their latest 13F filing, including Cathie Wood, Israel Englander, George Soros. The largest position is worth $116M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.